StonvexLoading…
StonvexStonvexStonvexCore line items from ALAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $308.36M | $852.52M | $581.94M | $351.37M |
Operating Income | $61.83M | $173.42M | $106.47M | $51.06M |
Net Income | $80.31M | $219.13M | $174.15M | $83.04M |
EPS (Diluted) | $0.44 | $1.22 | $0.97 | $0.47 |
Total Assets | $1.66B | $1.53B | $1.40B | $1.27B |
Total Liabilities | $165.27M | $168.19M | $129.45M | $135.69M |
Cash & Equivalents | $148.28M | $167.61M | $140.41M | $162.33M |
Free Cash Flow OCF − CapEx | $67.01M | $281.76M | $205.19M | $139.31M |
Shares Outstanding | 171.28M | 170.19M | 168.90M | 166.21M |